DCM
OACC

Driehaus Capital Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Driehaus Capital Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-670,072
Closed -$7.12M – 455
2025
Q4 		$7.12M Sell
670,072
-42,852
-6% -$453K 0.05% 292
2025
Q3 		$7.46M Sell
712,924
-44,284
-6% -$463K 0.05% 302
2025
Q2 		$7.94M Sell
757,208
-142,792
-16% -$1.48M 0.06% 277
2025
Q1 		$9.18M Buy
+900,000
New +$9.03M 0.09% 258

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Driehaus Capital Management's OACC Position: Q1 2026 in Review

Driehaus Capital Management sold out of Oaktree Acquisition Corp III Life Sciences (OACC) in Q1 2026, closing a stake of 670,072 shares — an estimated $7.12M sold.

Driehaus Capital Management first reported a position in OACC in Q1 2025 and held it in 4 quarters. The position peaked at $9.18M in Q1 2025. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Driehaus Capital Management reported no remaining Oaktree Acquisition Corp III Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Driehaus Capital Management sold 670,072 Oaktree Acquisition Corp III Life Sciences shares in Q1 2026, an estimated $7.12M.
  • Driehaus Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and held it in 4 quarters.
  • Driehaus Capital Management's Oaktree Acquisition Corp III Life Sciences position peaked at $9.18M in Q1 2025.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.